GGrantIndex
← Search

A PHASE I STUDY OF A COMBINATION OF YTTRIUM-90 LABELED ANTI-CEA ANTIBODY

$35,120M01FY2005RRNIH

University Of Southern California, Los Angeles CA

Investigators

Linked publications & trials

View original record on NIH RePORTER →